» Articles » PMID: 1682462

The Fluoroquinolones Exert a Reduced Rate of Kill Against Enterococcus Faecalis

Overview
Specialties Pharmacology
Pharmacy
Date 1991 Jul 1
PMID 1682462
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The bactericidal activities of ciprofloxacin, ofloxacin and DR-3355 have been investigated against Enterococcus faecalis, Staphylococcus aureus and Staphylococcus epidermidis over 24 h. The three fluoroquinolones were found to be rapidly bactericidal against the staphylococci, killing over 99% of the bacteria during the first 3 h of exposure with a further reduction in viability of approximately one logarithm occurring over the next 21 h. In contrast, the fluoroquinolones displayed a much slower rate of kill against E. faecalis, as little or no bactericidal activity was detected over the first 3 h for both E. faecalis ATCC19433 and a clinical isolate. At 6 h all three of the drugs were bactericidal against the enterococci although the amount of kill was not as great as against the staphylococci. However, at 24 h the amount of kill obtained with all three drugs was similar to that obtained for staphylococci exposed to these drugs. Ciprofloxacin, ofloxacin and DR-3355 were not active against E. faecalis ATCC19433 in phosphate buffered saline and therefore require cell division for their bactericidal activity against this species.

Citing Articles

Population Density Modulates Drug Inhibition and Gives Rise to Potential Bistability of Treatment Outcomes for Bacterial Infections.

Karslake J, Maltas J, Brumm P, Wood K PLoS Comput Biol. 2016; 12(10):e1005098.

PMID: 27764095 PMC: 5072716. DOI: 10.1371/journal.pcbi.1005098.


Comparative killing rates of fluoroquinolones and cell wall-active agents.

Fung-Tomc J, Gradelski E, Valera L, Kolek B, Bonner D Antimicrob Agents Chemother. 2000; 44(5):1377-80.

PMID: 10770784 PMC: 89877. DOI: 10.1128/AAC.44.5.1377-1380.2000.


DNA gyrase, topoisomerase IV, and the 4-quinolones.

Drlica K, Zhao X Microbiol Mol Biol Rev. 1997; 61(3):377-92.

PMID: 9293187 PMC: 232616. DOI: 10.1128/mmbr.61.3.377-392.1997.


Identification of a pKM101 region which confers a slow growth rate and interferes with susceptibility to quinolone in Escherichia coli AB1157.

Clerch B, Rivera E, Llagostera M J Bacteriol. 1996; 178(19):5568-72.

PMID: 8824598 PMC: 178392. DOI: 10.1128/jb.178.19.5568-5572.1996.


Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci.

Korten V, Tomayko J, Murray B Antimicrob Agents Chemother. 1994; 38(3):611-5.

PMID: 8203863 PMC: 284507. DOI: 10.1128/AAC.38.3.611.